Guggenheim Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,184
| Closed | -$247K | – | 1864 |
|
|
2024
Q2 | $247K | Buy |
6,184
+1,573
| +34% | +$62.9K | ﹤0.01% | 1703 |
|
|
2024
Q1 | $202K | Buy |
4,611
+133
| +3% | +$5.84K | ﹤0.01% | 1791 |
|
|
2023
Q4 | $277K | Sell |
4,478
-1,571
| -26% | -$97.2K | ﹤0.01% | 1702 |
|
|
2023
Q3 | $278K | Sell |
6,049
-78
| -1% | -$3.59K | ﹤0.01% | 1649 |
|
|
2023
Q2 | $352K | Sell |
6,127
-5,739
| -48% | -$330K | ﹤0.01% | 1607 |
|
|
2023
Q1 | $445K | Sell |
11,866
-6,303
| -35% | -$236K | ﹤0.01% | 1534 |
|
|
2022
Q4 | $509K | Buy |
18,169
+4,096
| +29% | +$115K | ﹤0.01% | 1477 |
|
|
2022
Q3 | $395K | Sell |
14,073
-1,171
| -8% | -$32.9K | ﹤0.01% | 1566 |
|
|
2022
Q2 | $531K | Sell |
15,244
-15,911
| -51% | -$554K | ﹤0.01% | 1555 |
|
|
2022
Q1 | $1.12M | Sell |
31,155
-3,036
| -9% | -$109K | 0.01% | 1304 |
|
|
2021
Q4 | $796K | Sell |
34,191
-2,865
| -8% | -$66.7K | ﹤0.01% | 1470 |
|
|
2021
Q3 | $704K | Buy |
+37,056
| New | +$704K | ﹤0.01% | 1594 |
|
|
2017
Q2 | – | Sell |
-12,003
| Closed | -$173K | – | 2831 |
|
|
2017
Q1 | $173K | Sell |
12,003
-62,715
| -84% | -$904K | ﹤0.01% | 2645 |
|
|
2016
Q4 | $1.38M | Sell |
74,718
-62,497
| -46% | -$1.15M | ﹤0.01% | 1946 |
|
|
2016
Q3 | $2.6M | Buy |
137,215
+58,349
| +74% | +$1.11M | 0.01% | 1442 |
|
|
2016
Q2 | $1.27M | Sell |
78,866
-18,799
| -19% | -$303K | ﹤0.01% | 1872 |
|
|
2016
Q1 | $1.17M | Buy |
97,665
+4,995
| +5% | +$59.9K | ﹤0.01% | 1954 |
|
|
2015
Q4 | $1.32M | Sell |
92,670
-16,971
| -15% | -$242K | ﹤0.01% | 1932 |
|
|
2015
Q3 | $1.28M | Sell |
109,641
-4,899
| -4% | -$57.3K | ﹤0.01% | 1947 |
|
|
2015
Q2 | $2.01M | Buy |
+114,540
| New | +$2.01M | 0.01% | 1763 |
|